ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Warszawa, Mazowieckie

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Warszawa, Mazowieckie, POL:

Supplementation With B. Infantis for Mitigation of Type 1 Diabetes Autoimmunity (SINT1A)

months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...

Enrolling
Diabetes Mellitus, Type 1
Dietary Supplement: Placebo
Dietary Supplement: B. infantis
Helmholtz Zentrum München

Warsaw, Poland and 7 other locations

Recently updated

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Warsaw, Poland and 59 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Warsaw, Mazowieckie, Poland and 652 other locations

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: Placebo
Biological: TCD601

Phase 2

ITBMed

Warsaw, Poland and 37 other locations

evaluate the efficacy, safety and pharmacokinetic (PK) properties of CPL207280 after multiple (14 days) administration in patients with type 2 diabetes...

Enrolling
Type 2 Diabetes
Drug: Placebo
Drug: CPL207280

Phase 2

Celon Pharma

Kajetany, Nadarzyn, Poland

This study will look at how much weight participants will lose and how much blood sugar control they achieve from the start to the end of the study....

Active, not recruiting
Diabetes Mellitus, Type 2
Obesity
Drug: Placebo
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 66 other locations

We are doing this study to learn more about how semaglutide may help fight chronic kidney disease in people with type 2 diabetes. We are doi...

Active, not recruiting
Diabetes Mellitus, Type 2
Chronic Kidney Disease
Drug: Placebo (Semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 32 other locations

levels when given along with semaglutide in patients with type 2 diabetes. Participants will get the medicine insulin icodec once a week in ...

Enrolling
Diabetes Mellitus, Type 2
Drug: Insulin Icodec
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Mazowieckie, Poland and 32 other locations

Locations recently updated

as insulin glargine in this form) taken daily in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar l...

Active, not recruiting
Type 2 Diabetes
Drug: IcoSema
Drug: Insulin glargine

Phase 3

Novo Nordisk
Novo Nordisk

Warszawa, Poland and 91 other locations

This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...

Active, not recruiting
Type 2 Diabetes Mellitus
Biological: Insulin
Drug: Placebo to ertugliflozin 5 mg

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Warszawa, Mazowieckie, Poland and 103 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems